Medical Science Liaison Neurology Position Available In St. Louis, Missouri
Tallo's Job Summary: This job listing in St. Louis - MO has been recently added. Tallo will add a summary here for this job shortly.
Job Description
Medical Science Liaison Neurology Job Description Description TSP is engaged in a direct hire search for one of our clients. Our customer is a leading global biopharmaceutical company focused on the development and commercialization of novel therapies to address high unmet medical needs and improve the lives of patients. As a result of the company’s Medical Affairs department expansion, our client is looking for a talented and motivated Medical Science Liaison Neurology to join the team as a scientific and therapeutic expert committed to scientific exchange within the healthcare community. This position may be filled at a senior level given the experience and background of the successful candidate. This is a field-based position.
Qualifications:
Doctoral degree required (PhD, PharmD, MD)
Prior experience in neurology-related field required. Preference given to those with pharmaceutical industry experience in multiple sclerosis. Immunology experience a plus
Previous experience (2+ years) as an MSL or in Medical Affairs strongly preferred
Experience in clinical research and/or direct patient care ideal
Exemplary written and verbal communication skills, with the ability to present complex information clearly to a variety of audience types
Adept at building and maintaining relationships with others
Proficient in the use of Microsoft Office applications
Demonstrated ability to adapt within a dynamic environment
Willingness to travel (75%) and easy access to a major metropolitan airport The anticipated salary range for this role is $170,000 – $215,000. TSP Talent Solutions and our customers are affirmative action/equal opportunity employers (Minorities/Females/Veterans/Disabled) Medical Science Liaison Neurology Taylor Strategy Partners
St. Louis, MO
Full Time
USD 170,000.00 – 215,000.00
per year Published on 05/22/2025